Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study |
| |
Authors: | Urata Yukitomo Uesato Ryoko Tanaka Dai Nakamura Yoshihide Motomura Shigeru |
| |
Affiliation: | Department of Rheumatology, Seihoku Chuo Hospital, Gosyogawara, Japan. yurata@dream.com |
| |
Abstract: |
|
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|